From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease

1. Chierrito, T.P.C.
2. Mantoani, S.P.
3. Roca, C.
4. Requena, C.
5. Sebastian-Perez, V.
6. Castillo, W.O.
7. Moreira, N.C.S.
8. Pérez, C.
9. Sakamoto-Hojo, E.T.
10. Takahashi, C.S.
11. Jiménez-Barbero, J.
12. Cañada, F.J.
13. Campillo, N.E.
14. Martinez, A.
15. Carvalho, I.